Market analysts predict the global bioactive fillings market will experience a 9.2 percent compound annual growth rate between 2017 and 2023.
Spinal Tech
Medtronic reported second quarter worldwide revenue dropped 4 percent due to the company's divestiture of the Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses to Cardinal Health.
The global interventional spine devices market is predicted to grow at a steady compound annual growth rate of 10.5 percent until 2021, according to MILTECH.
Although reporting $19.7 billion total sales in the third quarter of 2017, Johnson & Johnson's spine division saw a decline in sales, according to Market Realist.
Highmark issued a new medical policy, "Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)."
Advertisement
The FDA cleared 19 spine-related medical devices in October.
ReWalk Robotics opened a public offering Nov. 17, according to CTECH.
Bain & Company released a new report, "A Path to Faster Growth for Healthcare Companies."
Here are six key notes on orthopedic and spine device companies from the past week.
To improve clinical outcomes and lower healthcare costs, Invibio Biomaterial Solutions made strategic investments in clinical study expertise, component manufacturing facilities and component testing.